The goal of this clinical trial is to evaluate peri and post-operative outcomes as well as long-term survival of 3D IGRAPN compared to conventional Robot-Assisted Partial Nephrectomy (RAPN) for moderate and highly complex renal tumors.
The main questions aim to answer:
* peri-operative complications * oncological safety * long term renal function Participants will be asked to do undergo 3D-IGRAPN. Researchers will compare 3D-IGRAPN to RAPN to see if peri-operative outcomes are better in the experimental group.
Patients over 18 years
Indication of RAPN for suspicious renal tumor
Moderate or high complexity renal tumor (RENAL Nephrometry Score (NS) >7)
Da Vinci® surgical system available for the surgery
Medical contraindication to RAPN
Renal insufficiency forbidding iodine injection
Patient with allergy to iodinated contrast products
Patient concerned by articles L1121-5 to 8 of the French public health code (protected persons)
Parallel
Robot assisted partial nephrectomy with 3D image guidance
Procedure/Surgerypatient have a partial nephrectomy for renal complex tumor
TRIFECTA score
evaluating peri-operative outcome complications as well as oncological safety and long-term renal function preservation.
Recurrence free survival
Recurrence-free survival and Overall survival
Overall survival
Overall Survival
Number of Conversion to radical nephrectomy
Need to convert to radical nephrectomy for intra-operative reasons
rate of Off clamp or superselective ischemia
use of techniques without renal artery clamping
Click on the lead sponsor to view all of their trials.
